Stock Analysis on Net

Baxter International Inc. (NYSE:BAX)

This company has been moved to the archive! The financial data has not been updated since August 4, 2016.

Analysis of Liquidity Ratios

Microsoft Excel

Liquidity Ratios (Summary)

Baxter International Inc., liquidity ratios

Microsoft Excel
Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Current ratio 2.05 1.71 1.69 1.95 1.78
Quick ratio 1.58 0.95 0.96 1.20 1.10
Cash ratio 1.28 0.48 0.46 0.69 0.60

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Baxter International Inc. current ratio improved from 2013 to 2014 and from 2014 to 2015.
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Baxter International Inc. quick ratio deteriorated from 2013 to 2014 but then improved from 2014 to 2015 exceeding 2013 level.
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Baxter International Inc. cash ratio improved from 2013 to 2014 and from 2014 to 2015.

Current Ratio

Baxter International Inc., current ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Selected Financial Data (US$ in millions)
Current assets 11,796 10,351 10,004 9,260 8,650
Current liabilities 5,750 6,042 5,906 4,759 4,857
Liquidity Ratio
Current ratio1 2.05 1.71 1.69 1.95 1.78
Benchmarks
Current Ratio, Competitors2
Abbott Laboratories
Cigna Group
CVS Health Corp.
Danaher Corp.
Elevance Health Inc.
Humana Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

1 2015 Calculation
Current ratio = Current assets ÷ Current liabilities
= 11,796 ÷ 5,750 = 2.05

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Baxter International Inc. current ratio improved from 2013 to 2014 and from 2014 to 2015.

Quick Ratio

Baxter International Inc., quick ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Selected Financial Data (US$ in millions)
Cash and equivalents 2,213 2,925 2,733 3,270 2,905
Accounts and other current receivables, net 1,731 2,803 2,911 2,425 2,420
Investment in Baxalta common stock 5,148
Total quick assets 9,092 5,728 5,644 5,695 5,325
 
Current liabilities 5,750 6,042 5,906 4,759 4,857
Liquidity Ratio
Quick ratio1 1.58 0.95 0.96 1.20 1.10
Benchmarks
Quick Ratio, Competitors2
Abbott Laboratories
Cigna Group
CVS Health Corp.
Danaher Corp.
Elevance Health Inc.
Humana Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

1 2015 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 9,092 ÷ 5,750 = 1.58

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Baxter International Inc. quick ratio deteriorated from 2013 to 2014 but then improved from 2014 to 2015 exceeding 2013 level.

Cash Ratio

Baxter International Inc., cash ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Selected Financial Data (US$ in millions)
Cash and equivalents 2,213 2,925 2,733 3,270 2,905
Investment in Baxalta common stock 5,148
Total cash assets 7,361 2,925 2,733 3,270 2,905
 
Current liabilities 5,750 6,042 5,906 4,759 4,857
Liquidity Ratio
Cash ratio1 1.28 0.48 0.46 0.69 0.60
Benchmarks
Cash Ratio, Competitors2
Abbott Laboratories
Cigna Group
CVS Health Corp.
Danaher Corp.
Elevance Health Inc.
Humana Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31).

1 2015 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 7,361 ÷ 5,750 = 1.28

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Baxter International Inc. cash ratio improved from 2013 to 2014 and from 2014 to 2015.